Free Trial

OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$3.65 -0.07 (-1.88%)
As of 01/17/2025 04:00 PM Eastern

OSUR vs. STAA, CERS, ANIK, UTMD, WST, COO, ALGN, MMSI, HAE, and ICUI

Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry.

OraSure Technologies vs.

STAAR Surgical (NASDAQ:STAA) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

OraSure Technologies has higher revenue and earnings than STAAR Surgical. OraSure Technologies is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$322.42M3.41$21.35M$0.4450.66
OraSure Technologies$405.47M0.67$53.65M$0.1524.33

In the previous week, STAAR Surgical had 9 more articles in the media than OraSure Technologies. MarketBeat recorded 12 mentions for STAAR Surgical and 3 mentions for OraSure Technologies. STAAR Surgical's average media sentiment score of 0.96 beat OraSure Technologies' score of 0.36 indicating that STAAR Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
OraSure Technologies
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

STAAR Surgical has a net margin of 6.38% compared to OraSure Technologies' net margin of 5.07%. STAAR Surgical's return on equity of 6.77% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical6.38% 6.77% 5.39%
OraSure Technologies 5.07%3.55%3.23%

STAAR Surgical presently has a consensus price target of $42.83, suggesting a potential upside of 92.16%. OraSure Technologies has a consensus price target of $5.50, suggesting a potential upside of 50.68%. Given STAAR Surgical's stronger consensus rating and higher probable upside, equities research analysts plainly believe STAAR Surgical is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
OraSure Technologies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

OraSure Technologies received 264 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 69.43% of users gave OraSure Technologies an outperform vote while only 55.28% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
288
55.28%
Underperform Votes
233
44.72%
OraSure TechnologiesOutperform Votes
552
69.43%
Underperform Votes
243
30.57%

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 3.4% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

STAAR Surgical has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Summary

STAAR Surgical beats OraSure Technologies on 13 of the 18 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$270.03M$4.54B$5.24B$8.95B
Dividend YieldN/A47.30%5.13%4.04%
P/E Ratio24.3325.9289.3017.34
Price / Sales0.6758.321,255.2478.66
Price / Cash2.7050.1443.8235.97
Price / Book0.627.795.324.79
Net Income$53.65M$13.87M$122.69M$225.00M
7 Day Performance0.83%1.46%-0.16%1.52%
1 Month Performance-3.69%11.95%3.75%4.68%
1 Year Performance-54.71%53.01%27.41%20.89%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
4.4121 of 5 stars
$3.65
-1.9%
$5.50
+50.7%
-55.1%$270.03M$405.47M24.33840Analyst Upgrade
News Coverage
STAA
STAAR Surgical
4.7786 of 5 stars
$22.29
-3.1%
$42.83
+92.2%
-24.4%$1.10B$341.22M50.661,115Insider Trade
News Coverage
CERS
Cerus
2.4274 of 5 stars
$1.67
+5.4%
$3.63
+117.7%
+7.8%$309.22M$176.23M-15.14290Short Interest ↑
ANIK
Anika Therapeutics
3.5752 of 5 stars
$15.91
+2.2%
$24.50
+54.0%
-28.4%$233.02M$164.17M-2.39300Positive News
UTMD
Utah Medical Products
3.0044 of 5 stars
$61.22
+0.5%
N/A-23.5%$207.66M$44.08M14.34180News Coverage
Positive News
WST
West Pharmaceutical Services
4.9039 of 5 stars
$339.69
+2.4%
$430.20
+26.6%
-1.0%$24.60B$2.88B50.4010,600Short Interest ↑
News Coverage
Positive News
COO
Cooper Companies
3.5816 of 5 stars
$91.80
+1.6%
$117.00
+27.5%
-1.5%$18.32B$3.90B47.0815,000News Coverage
ALGN
Align Technology
4.5692 of 5 stars
$212.96
+0.4%
$268.20
+25.9%
-13.6%$15.90B$3.96B36.3421,610News Coverage
MMSI
Merit Medical Systems
4.6119 of 5 stars
$96.02
-0.1%
$107.70
+12.2%
+32.0%$5.60B$1.33B47.076,950Analyst Forecast
News Coverage
HAE
Haemonetics
4.4869 of 5 stars
$79.56
+3.8%
$108.78
+36.7%
-10.9%$4.00B$1.36B33.013,657
ICUI
ICU Medical
4.16 of 5 stars
$157.39
+2.0%
$199.67
+26.9%
+76.1%$3.85B$2.34B-34.4414,000Short Interest ↑

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners